These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14583932)

  • 1. Anti-spasticity agents for multiple sclerosis.
    Shakespeare DT; Boggild M; Young C
    Cochrane Database Syst Rev; 2003; (4):CD001332. PubMed ID: 14583932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-spasticity agents for multiple sclerosis.
    Shakespeare DT; Boggild M; Young C
    Cochrane Database Syst Rev; 2001; (4):CD001332. PubMed ID: 11687107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-spasticity agents for multiple sclerosis.
    Shakespeare DT; Young CA; Boggild M
    Cochrane Database Syst Rev; 2000; 2003(4):CD001332. PubMed ID: 11034714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for ataxia in multiple sclerosis.
    Mills RJ; Yap L; Young CA
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005029. PubMed ID: 17253537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatments for spasticity and pain in multiple sclerosis: a systematic review.
    Beard S; Hunn A; Wight J
    Health Technol Assess; 2003; 7(40):iii, ix-x, 1-111. PubMed ID: 14636486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mixed treatment comparison on efficacy and safety of treatments for spasticity caused by multiple sclerosis: a systematic review and network meta-analysis.
    Fu X; Wang Y; Wang C; Wu H; Li J; Li M; Ma Q; Yang W
    Clin Rehabil; 2018 Jun; 32(6):713-721. PubMed ID: 29582713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L; Shellenberger MK; Davis CS
    Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for spasticity following spinal cord injury: results of a Cochrane systematic review.
    Taricco M; Pagliacci MC; Telaro E; Adone R
    Eura Medicophys; 2006 Mar; 42(1):5-15. PubMed ID: 16565680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine for fatigue in multiple sclerosis.
    Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
    Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spasticity in multiple sclerosis.
    Barnes MP; Kent RM; Semlyen JK; McMullen KM
    Neurorehabil Neural Repair; 2003 Mar; 17(1):66-70. PubMed ID: 12645447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amantadine for fatigue in multiple sclerosis.
    Pucci E; Branãs P; D'Amico R; Giuliani G; Solari A; Taus C
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002818. PubMed ID: 17253480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.
    Ashworth NL; Satkunam LE; Deforge D
    Cochrane Database Syst Rev; 2004; (1):CD004156. PubMed ID: 14974059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A benefit-risk assessment of baclofen in severe spinal spasticity.
    Dario A; Tomei G
    Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
    Olvey EL; Armstrong EP; Grizzle AJ
    Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O; Monteil-Roch I
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non pharmacological interventions for spasticity in multiple sclerosis.
    Amatya B; Khan F; La Mantia L; Demetrios M; Wade DT
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009974. PubMed ID: 23450612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interventions for spasticity following spinal cord injury.
    Taricco M; Adone R; Pagliacci C; Telaro E
    Cochrane Database Syst Rev; 2000; 2000(2):CD001131. PubMed ID: 10796750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.
    Chou R; Peterson K; Helfand M
    J Pain Symptom Manage; 2004 Aug; 28(2):140-75. PubMed ID: 15276195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.